Callan Family Office’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$825K Sell
10,951
-133
-1% -$9.48K 0.02% 614
2025
Q4
$685K Buy
+11,084
New +$652K 0.01% 667

Other funds holding NTR

Callan Family Office's NTR Position: Q1 2026 in Review

Callan Family Office reduced its Nutrien (NTR) stake by 1.2% in Q1 2026, selling an estimated $9.48K and leaving 10,951 shares worth $825K. The position accounts for 0.02% of the portfolio, ranked #614.

Callan Family Office first reported a position in NTR in Q4 2025 and has held it in 2 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Callan Family Office held 10,951 shares of Nutrien worth $825K as of Q1 2026.
  • Callan Family Office sold 133 Nutrien shares in Q1 2026, an estimated $9.48K.
  • Nutrien made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #614 holding.
  • Callan Family Office first reported a position in Nutrien in Q4 2025 and has held it in 2 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.